Announcements - OBI Pharma 台灣浩鼎

2022.Jun.27

Announcement of the status of implementation of the commitments during the up-listing at Taipei Exchange

2022.Jun.27

The Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board

2022.Jun.27

Announcement of 2022 shareholders' meeting resolution to lift the non-competition restrictions for new directors

2022.Jun.27

Announcement of 5th Remuneration Committee Members

2022.Jun.27

Announcement of 4th Audit Committee Members

2022.Jun.27

Announcement of Re-election of directors at the 2022 annual shareholders’ meeting

2022.Jun.27

Announcement of the Company’s important resolutions of the 2022 annual shareholders’ meeting

2022.Jun.22

Announcement on behalf of AP Biosciences of the BOD’s resolution to issue common shares through cash capital increase and the reference date

2022.Jun.16

Announcement on behalf of Amaran of important resolutions of the 2022 annual shareholders’ meeting

2022.May.13

Announcement on behalf of AP Biosciences of resolution of the Ex-rights record date of new shares through capitalization of capital surplus

News

Latest News

Events

Latest events